Search clinical trials for: Valaciclovir placebo

Total 53613 results

Heidelberg ImmunoTherapeutics GmbH

Completed

Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 2 Infection (MATCH-2)

Herpes Genitalis

Germany
University of Minnesota

Completed

ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation

Epstein-Barr Virus Infections | Cytomegalovirus Infections | Transplantation Infection

United States
GlaxoSmithKline

Completed

A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies.

Herpes Genitalis

United States, Canada, Brazil, Argentina, Chile
GlaxoSmithKline

Completed

VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies.

Infections, Herpesviridae

United States
University Hospital Birmingham NHS Foundation Trust
National Institute for Health Research, United Kingdom

Completed

Cytomegalovirus Control in Critical Care (CCCC)

Critical Illness

United Kingdom
Belfast Health and Social Care Trust
Queen's University, Belfast; Northern Ireland Clinical Trials Unit

Terminated

Epstein-Barr Virus Suppression in Chronic Obstructive Pulmonary Disease (EViSCO): a Phase 2 Randomised Control Trial (EViSCO)

COPD | EBV

United Kingdom
GlaxoSmithKline

Completed

Special Drug Use Investigation for VALTREX (Valaciclovir) (Pediatrics Chickenpox)

Varicella
Maruho Co., Ltd.

Completed

Phase III Study of ASP2151 in Herpes Zoster Patients

Herpes Zoster

Japan
GlaxoSmithKline

Completed

Pharmacokinetic Study Of Valaciclovir Hydrochloride Tablets

Virus Diseases
GlaxoSmithKline

Completed

A Safety And Tolerability Study Of Valaciclovir Oral Suspension In Infants And Children

Herpes Simplex

United States, Chile, South Africa
National Institute of Allergy and Infectious Diseases...

Completed

Valaciclovir to Prevent Transmission of Herpes Simplex Virus

Herpes Simplex

United States
GlaxoSmithKline

Completed

Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis)

Genital Herpes
GlaxoSmithKline

Completed

Evaluation Of Valaciclovir In Patients With Chickenpox

Varicella
University Medical Center Groningen
Stanley Medical Research Institute

Completed

To Rescue Cognition With Valaciclovir

Schizophrenia | Psychosis

Netherlands
Hugo Lovheim

Completed

Feasibility and Effects of Valaciclovir Treatment in Persons With Early Alzheimer's Disease (VALZ-Pilot)

Alzheimer Disease | Herpes Simplex | Mild Cognitive Impairment

Sweden
Professor Lorraine Harper
Wellcome Trust

Unknown

CMV Modulation of the Immune System in ANCA-associated Vasculitis (CANVAS)

ANCA Associated Vasculitis | CMV Infection

United Kingdom
M.D. Anderson Cancer Center
Roche Pharma AG

Completed

Oral Valganciclovir Versus Valacyclovir

Leukemia | Chronic Lymphocytic Leukemia

United States
Bristol-Myers Squibb

Completed

A Study of FV-100 Versus Valacyclovir in Patients With Herpes Zoster

Herpes Zoster | Shingles
Epiphany Biosciences

Completed

A Phase 2b Trial of EPB-348 for the Treatment of Herpes Zoster

Herpes Zoster

United States
Candel Therapeutics, Inc.

Active, not recruiting

Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer (PrTK03)

Prostate Cancer

United States, Puerto Rico
University of Washington
GlaxoSmithKline; Asociación Civil Impacta Salud y Educación, Peru

Completed

HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 Co-infected Men.

HIV Infection | Sexually Transmitted Diseases | Herpes Simplex

Peru
University of California, San Francisco

Recruiting

Valacyclovir in Pain Management of Acute Apical Abscesses

Pain, Acute | Acute Apical Abscess

United States
University of Washington
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and Breastfeeding (VIP)

HIV Infections | Herpes Simplex

Kenya
Assistance Publique - Hôpitaux de Paris

Terminated

In UTERO Treatment of Cytomegalovirus Congenital Infection With Valacyclovir (CYMEVAL)

Cytomegalovirus Infection | Viral Disease

France
University of Washington
GlaxoSmithKline; National Institutes of Health (NIH)

Completed

A Study of Valacyclovir to Suppress HSV and HIV Shedding in Coinfected Persons

HIV Infections | Herpes Simplex

United States
New York State Psychiatric Institute
Alzheimer's Association

Active, not recruiting

Valacyclovir for Mild Cognitive Impairment (VALMCI)

Mild Cognitive Impairment | Herpes Simplex 2 | Herpes Simplex 1

United States
University of Washington
GlaxoSmithKline; Asociación Civil Impacta Salud y Educación, Peru

Completed

HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons

HIV Infections | Sexually Transmitted Diseases | Herpes Simplex

Peru
NYU Langone Health
National Eye Institute (NEI); National Institutes of Health (NIH)

Active, not recruiting

Zoster Eye Disease Study (ZEDS)

Herpes Zoster Ophthalmicus

United States, Canada
University of Pittsburgh
Stanley Medical Research Institute; Dr. Ram Manohar Lohia Hospital

Completed

Valacyclovir Augmentation for Cognitive and Functional Remediation in Schizophrenia

Schizophrenia | Schizoaffective Disorder | Herpes Simplex

India
Uppsala University Hospital
GlaxoSmithKline; Pfizer

Completed

Scandinavian Bell's Palsy Study (SBPS)

Bell's Palsy
University Health Network, Toronto
CIHR Canadian HIV Trials Network

Completed

Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals? (VALIDATE)

HIV Infections | HIV Infection | Herpes Simplex Type II

Canada, United Kingdom, Argentina, Brazil
Astellas Pharma Inc

Completed

A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes

Herpes Genitalis

United States
Indiana University
University of California, Los Angeles; Yale University; University of Maryland; University of Kansas Medical Center and other collaborators

Completed

A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia (VISTA)

Schizophrenia

United States
University of California, San Francisco
Roche Pharma AG

Completed

Valganciclovir to Reduce T Cell Activation in HIV Infection

HIV Infections | Cytomegalovirus Infections

United States
Scott Palmer
Roche Pharma AG

Completed

Comparison of Oral Valganciclovir and Placebo for the Prevention of Cytomegalovirus (CMV) After Lung Transplantation (Valgan)

Cytomegalovirus Infections

United States
Candel Therapeutics, Inc.

Active, not recruiting

Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)

Prostate Cancer

United States, Mexico
aRigen Pharmaceuticals, Inc.

Unknown

Study to Compare Efficacy of Topical ARYS-01 (Sorivudine) Cream 3%, Oral Valaciclovir and Combination ARYS-01 Cream 3%/Oral Valaciclovir for Treatment of Herpes Zoster (Shingles)

Herpes Zoster | Postherpetic Neuralgia

United States
Karolinska Institutet
Karolinska University Hospital

Completed

Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection

Glioblastoma Multiforme | Cytomegalovirus Infection

Sweden
University of Washington
Hoffmann-La Roche

Completed

Suppression of Oral HHV8 Shedding With Valganciclovir

Human Herpesvirus 8

United States
Radboud University Medical Center

Completed

Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir (VALID-I)

Varicella Zoster Virus Infection | Herpes Simplex Virus Infection

Netherlands
Dr. Reddy's Laboratories Limited

Completed

Bioavailability Study of Valacycovir HCl Tablets, 1000 mg of Dr. Reddy's Under Fed Condition

Healthy

India
Dr. Reddy's Laboratories Limited

Completed

Bioavailability Study of Valacyclovir HCl Tablets, 1000 mg of Dr. Reddy's Under Fasting Conditions

Healthy

India
GlaxoSmithKline

Completed

VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2

Herpes Labialis

United States
Luis Eduardo Morales Buenrostro

Completed

Pharmacokinetic Parameters of Innovative Valganciclovir Versus Generic Valganciclovir

Kidney Transplantation | Pharmacokinetics | Cytomegalovirus Infections | Therapeutic Equivalency

Mexico
St. Justine's Hospital
Canadian Association of Emergency Physicians

Completed

Should We Use Oral Valacyclovir in Acute Herpetic Gingivostomatitis in Children?

Herpetic Gingivostomatitis

Canada
VA Office of Research and Development
GlaxoSmithKline

Completed

Evaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and HSV-2 Infection (Phase I)

Chronic Hepatitis C Infection

United States
University of Minnesota
Epiphany Biosciences

Completed

Activity of Valomaciclovir in Infectious Mononucleosis Due to Primary Epstein-Barr Virus Infection (Mono6)

Infectious Mononucleosis

United States
National Institute of Allergy and Infectious Diseases...

Completed

Long Term Treatment of Herpes Simplex Encephalitis (HSE) With Valacyclovir

Encephalitis

United States, Sweden, Canada, United Kingdom
National Institute of Allergy and Infectious Diseases...
Glaxo Wellcome

Withdrawn

The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected Children

HIV Infections | Herpes Simplex | Chickenpox
GlaxoSmithKline

Terminated

A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons

Herpes Genitalis

United States, Australia, Hong Kong

Search clinical trials for: Valaciclovir placebo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations